MOLN Molecular Partners AG

NASDAQ
$4.35

Molecular Partners AG (MOLN) is expected to report earnings on November 24, 2026, before the market open. The consensus earnings estimate is a loss of $0.46 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +0.0% since its last earnings release on August 25, 2026.

Molecular Partners AG Beat Consensus Estimates
Tuesday, August 25, 2026 · 1:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 24
Tuesday · 1:00 AM ET
Earnings Whisper
-
vs ($0.46)
Rev est $28.14M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $4.48

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Molecular Partners AG

Molecular Partners AG is a clinical-stage biotech company developing DARPin therapeutics, a new class of custom-built protein drugs designed to address challenges current modalities cannot.

Sector

Healthcare

Industry

Biotechnology